In @JAMACardio study, @BIDMChealth @SmithBIDMC scientists show nearly 6 in 10 US vs 3 in 10 Japanese older adults with diabetes quit semaglutide shots w/in 1 year. Lower discontinuation in Japan points to impact of costs, supply issues

🚨 A new, practical framework for evaluating the economic value of cardiovascular drugs, devices, and preventive strategies Just published in @JACCJournals and @CircAHA Here’s what’s new, why it matters, and how it will shape care. 🧵

The proposed “Most Favored Nation Drug Pricing” (MFN-DP) plan is the most ambitious plan yet to rein in US drug spending. How did we get here? How would MFN-DP work? What are the expected short, intermediate, & long-term consequences? Here are my top 10 takeaways (so far)- 1/

Fantastic talk by Dr Inoue @ki_endoepi on how to use machine learning to identify individuals who derive the greatest benefit from a treatment or policy. We really need to get past focusing on “average” effects! Thank you for spending this year with us @SmithBIDMC. @KyotoU_News

Check out our cardiac rehab in MI paper led by @EssaMJ90! Post-discharge outcomes for MI–CS remain suboptimal. Rehab is a 🎯 intervention, but participation is ⬇️ and inequitable ⚖️. Next step: tackling the why and fixing the gaps! @kardiologykazi @SmithBIDMC

The Smith Center will be at #AHA24 this weekend! Check out the full schedule here: https://t.co/DAF7K3Lyej

Here we introduce for you the paradox of rare diseases therapies (using tafamidis as example): despite a smaller targeted population these high cost drugs are blockbusters for pharmaceutical companies. Trilled wt this first piece under mentorship of @kardiologykazi @SmithBIDMC

https://t.co/s4J7TvMd81

Check out our recent cost-utility analysis of VA-ECMO for Cardiogenic Shock w/ Brazilian perspective, published on @ArquivosSBC! There is a gap for future RCTs including different patient profiles to confirm our findings. @Scolari_Fernand @GEICC3 @hospitalmoinhos

@wagner_nedel @azavascki

Using database linkage,we demonstrate the correlation between trends in respiratory infections—analyzing 24 different viruses and atypical bacteria via PCR—and climate variables in Brazil, providing insights for future targeted community-level prevention! https://t.co/icKSYaGzte

Out in @JAMACardio today: Environmental stressors like extreme temps, hurricanes, & wildfires associated w/ increased cardiovascular morbidity & mortality. Urgent action needed to mitigate risk, esp in vulnerable populations. #climatechange https://t.co/wHcA8lHYW6 @BIDMChealth

After years of listening and discussing with colleagues living in Brazil about your podcast, it was a pleasure to listen and meet you in person at @BidmcCvi @SmithBIDMC grand rounds ! Thank you @drjohnm for teaching us how to learn from skepticism but not nihilism

This is the worst natural catastrophe in the history of my region. Hundreds of cities flooded, including my own. 100+ people dead. 100.000+ people displaced. Millions affected.

Happy with the editorial published in the Brazilian Medical Association journal. This short piece discusses a topic that I love: have we appropriately selected the desired outcomes for older adults? Glad to work with mentors and colleagues highlighting older adults QoL as a goal

Happy to learn and work at the Smith Center this year! Let's make this year great one!

We are excited to welcome post-doctoral fellow @SrgioDecker to the Smith Center! Sérgio joins us from @hospitalmoinhos, and will be working with @kardiologykazi on health economics and cost-effectiveness research.

Patient mortality after cardiorespiratory arrest remains high. We show that capnography – technology to measure CPR quality – is cost-effective, suggesting adoption could improve mortality rates & reduce burden on health systems. New in @AmericanHeartJ https://t.co/IZA3s09Z0V

Let’s talk #BempedoicAcid for high-risk primary prevention in individuals with #statin intolerance   @JAMA_Current has important results for clinicians + plenty of intrigue (aka learning) for researchers. Fasten your seat belts –let’s go! 🧵1/ https://t.co/33fYpbmdrm

thank you @HBGMD, we are glad to participate in the 🥇editorial and talk about such an interesting topic at @journal_CHEST Critical Care!! 👏🤝Congrats @georgeanesi by the work